Bristol-Myers Squibb Co (BMY)
58.87
+0.64
(+1.10%)
USD |
NYSE |
Nov 22, 16:00
58.87
0.00 (0.00%)
After-Hours: 20:00
Bristol-Myers Squibb Cash from Operations (Quarterly): 5.591B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.591B |
| June 30, 2024 | 2.326B |
| March 31, 2024 | 2.834B |
| December 31, 2023 | 4.252B |
| September 30, 2023 | 4.751B |
| June 30, 2023 | 1.887B |
| March 31, 2023 | 2.97B |
| December 31, 2022 | 3.306B |
| September 30, 2022 | 3.687B |
| June 30, 2022 | 2.261B |
| March 31, 2022 | 3.812B |
| December 31, 2021 | 4.057B |
| September 30, 2021 | 5.266B |
| June 30, 2021 | 3.06B |
| March 31, 2021 | 3.824B |
| December 31, 2020 | 3.355B |
| September 30, 2020 | 2.267B |
| June 30, 2020 | 4.493B |
| March 31, 2020 | 3.937B |
| December 31, 2019 | 2.181B |
| September 30, 2019 | 2.556B |
| June 30, 2019 | 2.083B |
| March 31, 2019 | 1.39B |
| December 31, 2018 | 3.555B |
| September 30, 2018 | 1.279B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.057B |
| March 31, 2018 | 1.175B |
| December 31, 2017 | 1.117B |
| September 30, 2017 | 1.713B |
| June 30, 2017 | 1.584B |
| March 31, 2017 | 861.00M |
| December 31, 2016 | 1.443B |
| September 30, 2016 | 1.404B |
| June 30, 2016 | 439.00M |
| March 31, 2016 | -228.00M |
| December 31, 2015 | 884.00M |
| September 30, 2015 | 524.00M |
| June 30, 2015 | 71.00M |
| March 31, 2015 | 626.00M |
| December 31, 2014 | 572.00M |
| September 30, 2014 | 903.00M |
| June 30, 2014 | 1.056B |
| March 31, 2014 | 617.00M |
| December 31, 2013 | 1.41B |
| September 30, 2013 | 1.053B |
| June 30, 2013 | 1.51B |
| March 31, 2013 | -428.00M |
| December 31, 2012 | 836.00M |
| September 30, 2012 | 4.584B |
| June 30, 2012 | 1.134B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
1.887B
Minimum
Jun 2023
5.591B
Maximum
Sep 2024
3.506B
Average
3.521B
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 7.993B |
| Eli Lilly and Co | 3.712B |
| Merck & Co Inc | 9.291B |
| Pfizer Inc | 6.714B |
| AbbVie Inc | 5.447B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -219.00M |
| Cash from Financing (Quarterly) | -3.852B |
| Free Cash Flow | 13.80B |
| Free Cash Flow Per Share (Quarterly) | 2.593 |
| Free Cash Flow to Equity (Quarterly) | 7.904B |
| Free Cash Flow to Firm (Quarterly) | 5.633B |
| Free Cash Flow Yield | 11.56% |